Bulletin
Investor Alert

London Markets Open in:

HilleVax Inc.

NAS: HLVX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 4, 2022, 4:57 p.m.

/zigman2/quotes/234952647/composite

$

19.92

Change

+0.94 +4.95%

Volume

Volume 7,552

Quotes are delayed by 20 min

/zigman2/quotes/234952647/composite

Previous close

$ 18.33

$ 18.98

Change

+0.65 +3.55%

Day low

Day high

$17.31

$20.10

Open

52 week low

52 week high

$7.90

$24.42

Open

Aditya Kohli

Founder of Phathom Pharmaceuticals, Inc., Passage Bio, Inc., Scout Bio, Inc. and Recida Therapeutics, Inc., Aditya Kohli is an entrepreneur who currently holds the position of Chief Operating Officer & Director at HilleVax, Inc., Chief Business Officer for Phathom Pharmaceuticals, Inc. and Venture Partner at Frazier Management LLC. He is also on the board of Scout Bio, Inc. and Vice President for Frazier Life Sciences IX LP.

In the past Dr. Kohli held the position of Engagement Manager at McKinsey & Co., Inc.

He received an undergraduate degree and a graduate degree from Massachusetts Institute of Technology and a doctorate from the University of California, Berkeley.

Transactions

Date Shares Transaction Value

Officers and Executives

Dr. Robert M. Hershberg
Chairman, President & Chief Executive Officer
Dr. Aditya Kohli
Chief Operating Officer & Director
Mr. David A. Socks
Chief Financial & Business Officer
Dr. Astrid Borkowski
Chief Medical Officer
Mr. Paul S. Bavier
Secretary & Chief Administrative Officer
Dr. Gary Dubin
Director
Ms. Kaia Agarwal
Senior Vice President-Regulatory Affairs
Dr. Shelley Chu
Independent Director
Dr. Julie Louise Gerberding
Independent Director
Mr. Patrick J. Heron
Independent Director
Ms. Jeryl Lynn Hilleman
Independent Director
Dr. Jaime Sepulveda
Independent Director
Ms. Susan Silbermann
Independent Director
Link to MarketWatch's Slice.